ChemicalBook--->CAS DataBase List--->288154-17-6

288154-17-6

288154-17-6 Structure

288154-17-6 Structure
IdentificationBack Directory
[Name]

tert-butyl 4-(benzyloxycarbonylamino)-4-carbamoylpiperidine-1-carboxylate
[CAS]

288154-17-6
[Synonyms]

1-Boc-4-(Cbz-amino)-4-(aminocarbonyl)-piperidine
Pyrazolo[1,5-a]pyridine-3-carboxylicacid,9-bromo-
tert-Butyl 4-(Cbz-amino)-4-carbamoylpiperidine-1-carboxylate
tert-butyl 4-(benzyloxycarbonylamino)-4-carbamoylpiperidine-1-carboxylate
1-Piperidinecarboxylic acid, 4-(aminocarbonyl)-4-[[(phenylmethoxy)carbonyl]amino]-, 1,1-dimethylethyl ester
[Molecular Formula]

C19H27N3O5
[MDL Number]

MFCD17170923
[MOL File]

288154-17-6.mol
[Molecular Weight]

377.43
Chemical PropertiesBack Directory
[Boiling point ]

581.6±50.0 °C(Predicted)
[density ]

1.23±0.1 g/cm3(Predicted)
[storage temp. ]

2-8°C
[pka]

10.45±0.20(Predicted)
Safety DataBack Directory
[Symbol(GHS) ]

Exclamation Mark (GHS07)
GHS07
[Signal word ]

Warning
[Hazard statements ]

H302-H315-H319-H335
[Precautionary statements ]

P261-P305+P351+P338
Hazard InformationBack Directory
[Synthesis]

4-BENZYLOXYCARBONYLAMINO-PIPERIDINE-1,4-DICARBOXYLIC ACID MONO-TERT-BUTYL ESTER

288154-16-5

tert-butyl 4-(benzyloxycarbonylamino)-4-carbamoylpiperidine-1-carboxylate

288154-17-6

General procedure for the synthesis of tert-butyl 4-(benzyloxycarbonylamino)piperidine-1,4-dicarboxylate from mono-tert-butyl 4-benzyloxycarbonylaminopiperidine-1,4-dicarboxylate: firstly, 4-(benzyloxycarbonylamino)-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid (1A, 2.0 g, 1.0 eq.) was solubilized in DME (0.5 M), NMM (1.0 eq.) and IBCF (1.0 eq.) and reacted at -15 °C for 10 min. Subsequently, ammonia (1.5 eq.) was added and the reaction mixture was stirred at room temperature for 1.5 hours. After completion of the reaction (confirmed by LCMS analysis), it was partitioned with ethyl acetate and water. The organic phase was washed with brine, dried over Na2SO4, filtered and the solvent was removed under reduced pressure. The residue was purified by ether crystallization to afford tert-butyl 4-(benzyloxycarbonylamino)-4-carbamoylpiperidine-1-carboxylate (1B, 70% yield). 1B (1.0 equiv) and a catalytic amount of acetic acid were dissolved in MeOH (0.05 M) and hydrogenated at 50 °C through an H-cube hydrogenator equipped with a Pd/C column. After completion of the reaction, methanol was removed under reduced pressure and the product was washed twice with cold ether to afford tert-butyl 4-amino-4-carbamoyl piperidine-1-carboxylate (1C, 90% yield). 1C (0.3 M) was mixed with 2-chloro-1,1,1-trimethoxyethane (4.0 eq.) and acetic acid (2.0 eq.) and stirred at 118 °C for 12 hours. After removing the solvent under reduced pressure, the residue was purified by crystallization from cold ether to afford tert-butyl 2-(chloromethyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate (1D, 67% yield). 1D was dissolved in 2.0 M ammonia in 2-propanol solution (0.04 M), an excess of ammonia was drummed into a sealed tube and heated at 60 °C for 12 hours. Upon completion of the reaction (confirmed by LCMS analysis), the solvent was removed to afford tert-butyl 2-(aminomethyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate (1E), which did not require any further purification. eSI-MS: m/z 283.1 (M+H)+. For the deprotection step, 1E (1.0 eq.) was dissolved in CH2Cl2 and a 1.6:1 solution of CH2Cl2/TFA (final concentration 0.15 M) was slowly added at 0 °C. The reaction was completed within 30 min at 0°C (confirmed by LCMS analysis). Volatiles were removed under reduced pressure to afford the TFA salt of 2-(aminomethyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one (1G), which was ready for use without further purification.ESI-MS: m/z 183.1 (M+H)+.

[References]

[1] Patent: US2009/253725, 2009, A1. Location in patent: Page/Page column 51
[2] Journal of Medicinal Chemistry, 2000, vol. 43, # 12, p. 2387 - 2394
[3] Patent: WO2006/41830, 2006, A2. Location in patent: Page/Page column 61
[4] Patent: WO2006/44504, 2006, A1. Location in patent: Page/Page column 98
288154-17-6 suppliers list
Company Name: Tianjin Chempharmatech Co.,Ltd.  
Tel: 022-66211079 13212288319
Website: www.chempharmatech.com
Company Name: Chengdu Firster Pharmaceutical Co., Ltd.  
Tel: 028-87078428 028-87074958
Website: http://www.cdfirster.com
Company Name: SanoChem (Chengdu) Tech. Co., Ltd.  
Tel: 28-87999436 02887999436
Website: http://www.sano-chem.com
Company Name: Amatek Scientific Co. Ltd.  
Tel: 0512-56316828
Website: http://www.amateksci.com
Company Name: Aikon International Limited  
Tel: 025-58859352 19370895928
Website: www.aikonchem.com
Company Name: Energy Chemical  
Tel: 021-58432009 400-005-6266
Website: http://www.energy-chemical.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-1647117 13681763483
Website: https://www.bidepharm.com/
Company Name: Bide Pharmatech Ltd.  
Tel: 400-6005915
Website: www.picasso-e.com/
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 010-50973130 17801761073
Website: www.solarbio.com/
Company Name: Shanghai Jieshikai Biotechnology Co. , Ltd.  
Tel: 021-57520305 13795461237
Website: www.jskchem.com
Company Name: Shanxi Nuocheng Biotechnology Co., Ltd  
Tel: 17835231871
Website: https://www.ncwbio.com
Company Name: Synthonix Inc  
Tel: 001-9198759277
Website: www.synthonix.com
Company Name: A.J Chemicals  
Tel: 91-9810153283
Website: www.ajchemicals.com
Company Name: Combi-Blocks Inc.  
Tel: 858 635 8950
Website: www.combi-blocks.com
Tags:288154-17-6 Related Product Information